Human tumor response to novel natural product compounds using the POAI biobank and active machine learning
Predictive Oncology
MAY 14, 2025
Several NPDC compounds demonstrated efficacy across multiple tumor types and are now well positioned for further development. Given that the POAI platform provides a clinically relevant and accelerated pathway to natural compound screening. Complete the form below to download the white paper.
Let's personalize your content